Patent litigation between Teva and Amgen Inc. relating to Neutroval(TM) (a recombinant form of human G-CSF) has been settled, Amgen disclosed in its August 8, 2011, Form 10-Q filing with…
A patent infringement suit filed by Merck & Co. Inc. against Sandoz Inc. relating to AzaSite is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with the…
Infosint S.A.’s Irish patent has been revoked following a UK trial court ruling in a patent infringement suit it filed against Forest and H. Lundbeck A/S, a unit of Forest…
A patent infringement suit filed by Merck & Co. Inc. against Teva Parenteral Medicines, Inc. relating to Integrilin is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing…
Merck & Co. Inc. continues to cooperate with the Federal Trade Commission after it received a Civil Investigative Demand regarding a patent settlement agreement it entered with Ranbaxy Laboratories Ltd.,…
A patent infringement suit filed by Pfizer Inc. against Teva Parenteral Medicines Inc. relating to Zyvox (linezolid) is pending.
In December 2009, Teva Parenteral notified the Company that it had filed…
Patent infringement actions filed by Pfizer Inc. against Watson and Ranbaxy Laboratories Limited relating to Rapamune (sirolimus) are pending.
In March 2010, Watson and Ranbaxy notified the Company that they had…
Patent infringement actions filed by Pfizer Inc. against Lupin Limited and Novel Laboratories, Inc. relating to Lyrica (pregabalin) are pending.
In August and November 2010, respectively, Lupin and Novel notified the…
A patent infringement action filed by Novartis Vaccines and Diagnostics, Inc. against Wyeth relating to ReFacto and Xyntha is pending. The Company acquired Wyeth in 2009.
In February 2008, Novartis filed…
Patent infringement actions filed by Pfizer Inc. against against Teva USA with respect to Detrol LA (tolterodine) and against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva USA, with…